Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

ANTI-GANGLIOSIDE ANTIBODIES - ANVISA Registration 80102512136

Access comprehensive regulatory information for ANTI-GANGLIOSIDE ANTIBODIES in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80102512136 and manufactured by BUHLMANN LABORATORIES AG. The registration is held by VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 2 companies making the same product including BUHLMANN LABORATORIES AG, EUROIMMUN AG, and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
2 Competitors
4 Recent Registrations
80102512136
Registration Details
ANVISA Registration Number: 80102512136
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

BÜHLMANN GanglioCombi Light ELISA
Risk Class II

Registration Details

80102512136

25351167783201899

04718143000194

Company Information

Switzerland
PT: SUÍÇA

Dates and Status

Oct 29, 2018

VIGENTE

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "ANTI-GANGLIOSIDE ANTIBODIES"